1.Fumarate hydratase deficient uterine leiomyoma: a clinicopathological and molecular analysis of 80 cases.
Xiao Xi WANG ; Yan LIU ; Ling Chao LIU ; Yu Xiang WANG ; Jing YANG ; A Jin HU ; Bo ZHANG ; Cong Rong LIU
Chinese Journal of Pathology 2023;52(6):574-579
		                        		
		                        			
		                        			Objective: To investigate the clinicopathologic and molecular characteristics of fumarate hydratase (FH) deficient uterine leiomyoma. Methods: Eighty cases of FH deficient uterine leiomyoma were diagnosed from April 2018 to September 2022 in Department of Pathology, Peking University Third Hospital. Sanger sequencing of FH gene exons (exon 1-10) were performed on tumor tissues and matched non-tumor tissues/peripheral blood for all cases. FH immunohistochemistry were performed in 74 cases; S-(2-succino)-cysteine (2SC) were also detected by immunohistochemistry in five cases. Results: Patients' age ranged from 18 to 54 (36.0±7.5) years, with more than 60% exhibiting clinical symptoms of multiple and large leiomyomas (the median diameter was 70 mm). More than four histologic features, including staghorn vasculature, alveolar-pattern edema, bizarre nuclei, oval nuclei arranged in chains, prominent eosinophilic nucleoli with perinucleolar haloes and eosinophilic intracytoplasmic globules were observed in 98.5% (67/68) patients. The immunohistochemical sensitivity of FH and 2SC were 97.3% and 100%, respectively. Based on the Sanger sequencing results, the cases were divided into germline variant group (31 cases), somatic variant group (29 cases) and no variant group (20 cases). Sixty-nine percent (20/29) of the patients with FH germline variation had clear family history. Conclusions: Clinical features, histological morphology, FH and 2SC immunohistochemistry and Sanger sequencing have their own significance and limitations in differential diagnosis of FH deficient uterine leiomyoma. In clinical practice, the above information should be fully integrated and studied for accurate pathologic diagnosis and selection of patients with FH germline variation.
		                        		
		                        		
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Adolescent
		                        			;
		                        		
		                        			Young Adult
		                        			;
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Fumarate Hydratase/genetics*
		                        			;
		                        		
		                        			Uterine Neoplasms/pathology*
		                        			;
		                        		
		                        			Leiomyoma/pathology*
		                        			;
		                        		
		                        			Germ-Line Mutation
		                        			;
		                        		
		                        			Diagnosis, Differential
		                        			;
		                        		
		                        			Leiomyomatosis/pathology*
		                        			;
		                        		
		                        			Carcinoma, Renal Cell/diagnosis*
		                        			
		                        		
		                        	
3.Analysis of phenotype and FH gene variation in a pedigree affected with hereditary leiomyomatosis and renal cell carcinoma syndrome.
Yilin GUO ; Lu WANG ; Zhen XU ; Yangyang BAI ; Wuliang WANG ; Huifang WU ; Yingjie SUN
Chinese Journal of Medical Genetics 2022;39(5):494-498
		                        		
		                        			OBJECTIVE:
		                        			To analyze clinical phenotype and genetic variants in a Chinese pedigree of hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome.
		                        		
		                        			METHODS:
		                        			Whole exome sequencing was carried out for the proband from the pedigree. Suspected FH gene variants were validated by Sanger sequencing. Clinical manifestation and histopathological examination were used to analyze the pedigree comprehensively.
		                        		
		                        			RESULTS:
		                        			The pedigree met the clinical diagnostic criteria for HLRCC syndrome. The whole exome sequencing showed that the FH gene of the proband had a heterozygous missense variant of c.1490T>C (p.F497S), which was consistent with the Sanger sequencing. The mother, daughter and son of the proband all had the heterozygous missense variant of c.1490T>C (p.F497S). According to the American Society of Medical Genetics and Genomics Classification Standards and Guidelines for Genetic Variations, c.1490T>C (p.F497S) (PM2+PP1-M+PP3+PP4) was a possible pathogenic variant. Based on our literature search, this variant was a new variant that had not been reported.
		                        		
		                        			CONCLUSION
		                        			The FH gene missense variant of c.1490T>C (p.F497S) may be the cause of the HLRCC syndrome pedigree, which provides a basis for the genetic diagnosis and genetic counseling of the HLRCC syndrome.
		                        		
		                        		
		                        		
		                        			Carcinoma, Renal Cell/genetics*
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Kidney Neoplasms/genetics*
		                        			;
		                        		
		                        			Leiomyomatosis/pathology*
		                        			;
		                        		
		                        			Mutation
		                        			;
		                        		
		                        			Neoplastic Syndromes, Hereditary
		                        			;
		                        		
		                        			Pedigree
		                        			;
		                        		
		                        			Phenotype
		                        			;
		                        		
		                        			Skin Neoplasms
		                        			;
		                        		
		                        			Uterine Neoplasms
		                        			
		                        		
		                        	
4.Aberrant uterine leiomyomas with extrauterine manifestation: intravenous leiomyomatosis and benign metastasizing leiomyomas.
Yoo Na KIM ; Kyung Jin EOH ; Jung Yun LEE ; Eun Ji NAM ; Sunghoon KIM ; Sang Wun KIM ; Young Tae KIM
Obstetrics & Gynecology Science 2018;61(4):509-519
		                        		
		                        			
		                        			OBJECTIVE: Intravenous leiomyomatosis (IVL) and benign metastasizing leiomyoma (BML) are uncommon variants of benign uterine leiomyomas with extrauterine manifestations. Categorizing the extent of disease allows clinicians to delineate the clinical spectrum and the level of sophistication for complete surgical resection. METHODS: Twelve patients with IVL and BML were reviewed. They were divided into early versus late stage disease groups, and initial manifestation, clinical characteristics, laboratory values, surgical pathology, and follow up data were summarized. RESULTS: Patients were mostly pre- or peri-menopausal and parous. Patients with late stage disease were more likely to present with cardiac symptoms or abnormal findings on chest X-ray, whereas those with early stage disease presented with classical leiomyoma symptoms including heavy menstrual bleeding, increased myoma size, or lower abdominal discomfort. Tumor marker levels were within normal ranges. A trend of higher neutrophil to leukocyte ratio was observed in the late versus the early stage group (10.4 vs. 1.51, P=0.07); the platelet leukocyte ratio was statistically higher in patients with late stage IVL (0.23 vs. 0.13, P=0.04). The overall recurrence rate was 25%. No recurrence was observed in stage I or stage III IVL groups, while 50% of the stage II IVL group showed recurrence in the pelvic cavity. CONCLUSION: IVL and BML are benign myoma variants with paradoxically metastatic clinical presentation. Careful inquiry of systemic symptoms, the presence of underlying systemic inflammation, and a high index of suspicion are required for preoperative diagnosis. Furthermore, a multidisciplinary approach is necessary to improve outcomes of surgical resection.
		                        		
		                        		
		                        		
		                        			Blood Platelets
		                        			;
		                        		
		                        			Diagnosis
		                        			;
		                        		
		                        			Follow-Up Studies
		                        			;
		                        		
		                        			Hemorrhage
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Inflammation
		                        			;
		                        		
		                        			Leiomyoma*
		                        			;
		                        		
		                        			Leiomyomatosis*
		                        			;
		                        		
		                        			Leukocytes
		                        			;
		                        		
		                        			Myoma
		                        			;
		                        		
		                        			Neoplasm Metastasis
		                        			;
		                        		
		                        			Neutrophils
		                        			;
		                        		
		                        			Pathology, Surgical
		                        			;
		                        		
		                        			Recurrence
		                        			;
		                        		
		                        			Reference Values
		                        			;
		                        		
		                        			Smooth Muscle Tumor
		                        			;
		                        		
		                        			Thorax
		                        			
		                        		
		                        	
5.Surgical Treatment Strategies of Intravenous Leiomyomatosis withRight Cardiac Cavities Extension.
Guo-Tao MA ; Qi MIAO ; Xing-Rong LIU ; Chao-Ji ZHANG ; Yue-Hong ZHENG ; Jiang SHAO ; Ning-Hai CHENG ; Shun-da DU ; Jian-Zhou LIU ; Chao JIANG
Acta Academiae Medicinae Sinicae 2016;38(4):438-443
		                        		
		                        			
		                        			Objective To investigate the diagnosis and surgical treatment strategies of intravenous leiomyomatosis(IVL)extending through inferior vena cava into the right cardiac cavities. Methods Thirty patients of IVL extending through inferior vena cava into the right cardiac cavities were treated in Peking Union Medical College Hospital from November 2002 to January 2015.The following variables were studied: age,cardiopulmonary bypass time,deep hypothermic circulatory arrest time,origins of IVL,blood loss,duration of post-operative hospital stay,hospitalization expenses,edema of lower extremity,blood transfusion,postoperative complication,residual IVL,and re-grow or recurrence. Results Thirteen of 30 patients reported double lower limb edema. The cardiopulmonary bypass was applied in 27 cases,and the average duration of cardiopulmonary bypass was(106.9±53.7)min. Then,21 patients were treated with the deep hypothermic circulatory arrest,and the mean time was(28.2±11.6) min. The tumors originated from the genital veins in 9 cases,the iliac vein in 13 cases,and both veins in 8 cases. The average intra-operative blood loss volume was (2060.5±2012.3)ml,and 21 patients received blood transfusion. The average hospitalization time was(18.9±8.3)days and the average hospitalization expenses was (80 840.4±28 264.2)RMB yuan. While 14 patients had postoperative complications,there was no serious postoperative complication or death.All patients have shown a favorable outcome.Conclusions Tumor embolus extending through inferior vena cava into the right cardiac cavities should be suspected in patients with multiple hysteromyoma. Successful therapy for IVL with right cardiac cavities extension is dependent on reasonable surgical treatment strategies. Surgical removal of the ovaries is vital to avoid IVL re-grow or recurrence.
		                        		
		                        		
		                        		
		                        			Cardiopulmonary Bypass
		                        			;
		                        		
		                        			Circulatory Arrest, Deep Hypothermia Induced
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Heart Neoplasms
		                        			;
		                        		
		                        			surgery
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Leiomyomatosis
		                        			;
		                        		
		                        			surgery
		                        			;
		                        		
		                        			Length of Stay
		                        			;
		                        		
		                        			Neoplasm Recurrence, Local
		                        			;
		                        		
		                        			Ovary
		                        			;
		                        		
		                        			Postoperative Complications
		                        			;
		                        		
		                        			Vascular Neoplasms
		                        			;
		                        		
		                        			surgery
		                        			;
		                        		
		                        			Veins
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			Vena Cava, Inferior
		                        			;
		                        		
		                        			pathology
		                        			
		                        		
		                        	
6.Uterine Intravenous Leiomyomatosis with Intracardiac Extension and Pulmonary Benign Metastases on FDG PET/CT: A Case Report.
Hui Chun WANG ; Yu Bin WANG ; Xiao Hong CHEN ; Lan Lan CUI
Korean Journal of Radiology 2016;17(2):289-294
		                        		
		                        			
		                        			A 48-year-old woman presented with a 50-day history of irregular vaginal bleeding and lower abdominal pain. Ultrasound indicated an extremely large occupying lesion in the pelvic cavity that was highly suggestive of malignancy. Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) was performed to further assess the nature of pelvic abnormality. PET/CT images demonstrated a diffusely lobulated mass ranging from cervix up to the inferior pole of kidneys with mild FDG uptake. Simultaneously, multiple nodules in bilateral lungs and a hypodense lesion in the right ventricle were shown without FDG-avidity. Based on the imaging results, the presumptive diagnosis was uterine intravenous leiomyomatosis with intracardiac extension and pulmonary benign metastases, which was subsequently confirmed by MRI and the lesion biopsy.
		                        		
		                        		
		                        		
		                        			Female
		                        			;
		                        		
		                        			Fluorodeoxyglucose F18/chemistry
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Leiomyoma/pathology/radiography
		                        			;
		                        		
		                        			Leiomyomatosis/pathology/*radiography
		                        			;
		                        		
		                        			Lung Neoplasms/radiography/*secondary
		                        			;
		                        		
		                        			Magnetic Resonance Imaging
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Positron-Emission Tomography
		                        			;
		                        		
		                        			Tomography, X-Ray Computed
		                        			;
		                        		
		                        			Uterine Neoplasms/pathology/radiography
		                        			;
		                        		
		                        			Vena Cava, Inferior/pathology
		                        			
		                        		
		                        	
7.Clinicopathologic features of intravenous leiomyomatosis with intracardiac extension.
Jianfeng SHANG ; Dong CHEN ; Wei FANG ; Ying WU ; Yanwei LI ; Wei WANG ; Fengru SHI ;
Chinese Journal of Pathology 2014;43(6):408-411
OBJECTIVETo investigate clinicopathological features, immunophenotype and differential diagnosis of intravenous leiomyomatosis with intracardiac extension.
METHODSClinical manifestations, morphologic features, and immunohistochemical staining were retrospectively analyzed in 19 cases of intravenous leiomyomatosis with intracardiac extension.
RESULTSThe patients' age ranged from 33 to 59 years (mean 44 years). Clinical presentation included chest tightness, palpitation, dyspnea, edema of low extremity, abdominal distention or hypermenorrhea. However, a few patients were asymptomatic. Grossly, intravenous leiomyomatosis in most cases demonstrated coiled or nodular growth within the myometrium with worm-like involvement of the uterine vein in broad ligament or other pelvic veins with continued extension into the vena cava and the heart. The intravenous tumor surface was generally smooth and rubbery, with a greyish-white color. Microscopically, the tumors were composed of spindle cells with rare mitotic figures and the presence of abundant thick-walled vessels. Marked fibrosis, hyalinization, myxoid and edematous changes were common. The tumor cells were positive for SMA, ER, PR and desmin but negative for HMB45 and S-100. CD10 and CD34 were positive in 4 patients and negative in the remaining cases.
CONCLUSIONIntravenous leiomyomatosis with intracardiac extension is a rare disease among women of child-bearing age, with specific morphologic manifestations and immunohistochemical profiles.
Adult ; Diagnosis, Differential ; Female ; Humans ; Leiomyomatosis ; diagnosis ; pathology ; Middle Aged ; Retrospective Studies ; Uterus ; pathology ; Vena Cava, Inferior ; pathology
8.Intravascular leiomyomatosis with extrarenal rhabdoid cells: report of a case.
Hongjie SONG ; Yujuan JI ; Bingyu CHEN
Chinese Journal of Pathology 2014;43(2):128-130
		                        		
		                        		
		                        		
		                        			Actins
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Calcium-Binding Proteins
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Calmodulin-Binding Proteins
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Desmin
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Diagnosis, Differential
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Hysterectomy
		                        			;
		                        		
		                        			Leiomyoma, Epithelioid
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			Leiomyomatosis
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			surgery
		                        			;
		                        		
		                        			Leiomyosarcoma
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			Microfilament Proteins
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Receptors, Estrogen
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Receptors, Progesterone
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Rhabdoid Tumor
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			surgery
		                        			;
		                        		
		                        			Sarcoma, Endometrial Stromal
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			Uterine Neoplasms
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			surgery
		                        			;
		                        		
		                        			Vascular Neoplasms
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			surgery
		                        			;
		                        		
		                        			Veins
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			Vimentin
		                        			;
		                        		
		                        			metabolism
		                        			
		                        		
		                        	
9.Ultrasonic characteristics of intravenous leiomyomatosis with intracardiac extension.
Xiao-dong ZHANG ; Li-gang FANG ; Sheng CAI ; Ya-hong WANG ; Zhong-hui XU ; Lei WANG ; Jian-chu LI
Acta Academiae Medicinae Sinicae 2013;35(1):69-73
OBJECTIVETo explore the sonographic characteristics of intraveous leiomyomatosis (IVL) with intracardiac extension and improve its diagnosis.
METHODSThe clinical and sonographic data of 13 female patients with pathologically confirmed IVL with intracardiac extension who were treated in our hospital between 2002 and 2012 were retrospectively analyzed. These patients aged 44 years old (range: 38-49 years), and 10 of them were first-episode patients and the remaining 3 were recurrent patients. Eight patients had a history of hysterectomy for leiomyoma.
RESULTSThe first-episode symptoms included exertional chest tightness and shortness of breath (n=5), abdominal distention and edema of low extermity (n=4), exertional palpitation of cardiac origin (n=3), and menorrhagia (n=1). Ultrasonography showed that all patients had isoechoic or hypoechoic tumors extended through the inferior vena cava into right heart chambers (62% in right atrium alone and 38% in right ventricle and atrium). Nine masses in right heart chamber (69.2%) were oval and 4 (30.8%) were serpentine, which were all with well-demarcated borders and most (80%) with heteroechogenic texture. Ten patients had hypoechoic or mixed echoic tumors in pelvic cavity or uterus, and 6 of them had abundant blood flow.
CONCLUSIONSIVL with intracardiac extension has certain sonographic characteristics. Ultrasonography is a valuable tool in the diagnosis of IVL with intracardiac extension.
Adult ; Female ; Humans ; Leiomyomatosis ; diagnostic imaging ; pathology ; Middle Aged ; Myocardium ; pathology ; Retrospective Studies ; Ultrasonography ; Vascular Neoplasms ; diagnostic imaging ; pathology
10.Wolffian adnexal tumor: report of a case.
Ren-qiao LIU ; Zhen-huan ZHANG ; Min-hong PAN ; Zhi-hong ZHANG ; Qin-he FAN
Chinese Journal of Pathology 2013;42(7):476-477
		                        		
		                        		
		                        		
		                        			Adenoma
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			surgery
		                        			;
		                        		
		                        			ultrastructure
		                        			;
		                        		
		                        			Adnexa Uteri
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			surgery
		                        			;
		                        		
		                        			Adnexal Diseases
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			surgery
		                        			;
		                        		
		                        			Carcinoma, Endometrioid
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			Diagnosis, Differential
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Granulosa Cell Tumor
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Hysterectomy
		                        			;
		                        		
		                        			Keratins
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Leiomyomatosis
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			surgery
		                        			;
		                        		
		                        			Microscopy, Electron
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Neoplasms, Multiple Primary
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			surgery
		                        			;
		                        		
		                        			ultrastructure
		                        			;
		                        		
		                        			Sertoli-Leydig Cell Tumor
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			Uterine Neoplasms
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			surgery
		                        			;
		                        		
		                        			Vimentin
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			WT1 Proteins
		                        			;
		                        		
		                        			metabolism
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail